The discovery of a 'biomarker panel' could have a profound impact on the ability to identify patients at risk of developing PC at an earlier stage.
Up to half of all people living with Alzheimer’s Disease in Ireland remain undiagnosed. A new blood test may have the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback